학술논문
Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience
Document Type
Abstract
Author
Source
In Blood 29 November 2018 132 Supplement 1:3383-3383
Subject
Language
ISSN
0006-4971